+1,660.9%
SNDK vs EMR
+25.1%
+1,635.8%
-72.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -16.1% | -4.2% | -11.8% | -10.6% |
| 7D | -28.4% | -9.3% | -19.1% | -18.3% |
| 30D | -54.0% | -7.1% | -46.9% | -48.2% |
| 3M | -60.4% | -2.1% | -58.3% | -58.3% |
| 6M | -54.5% | +14.4% | -68.9% | -59.3% |
| YTD | +167.0% | +15.4% | +151.6% | +115.9% |
| 1Y | +223.5% | +23.8% | +199.7% | +137.1% |
| All | +1,660.9% | +25.1% | +1,635.8% | +1,168.3% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling